Biotech · Private company · Cheshire, CT, US
Recombinant Technologies, LLC
Track this companyFree. Adds Recombinant Technologies, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Novel Extracorporeal Device 'Amytrapper' To Remove Beta Amyloid In Alzheimer'sDiseaseFiscal year 2025 · $625.4KNIH RePORTER 5R44AG057327-06 · fetched Nov 12, 2026
- Novel Extracorporeal Device 'Amytrapper' To Remove Beta Amyloid In Alzheimer'sDiseaseFiscal year 2024 · $784.2KNIH RePORTER 5R44AG057327-05 · fetched Nov 12, 2026